Skip to main content

BMS Scholar Helps Lead Cancer Research Team Harnessing Protein Power to Stop Tumor Growth

Marxa stands with her arm draping the back of a chair in her lab
Dr. Marxa Figuieredo pictured in her lab. (Purdue University, Rebecca McElhoe)

Dr. Marxa Figueiredo, associate professor of Basic Medical Sciences in the College of Veterinary Medicine, played a leadership role on a team of Purdue University scientists who have created a new therapy option that may help halt tumor growth in certain cancers such as prostate, which is among the most common types of cancer in men.  In 2018, approximately 324,000 men died from cancer in the United States. The combination of lung cancer, prostate cancer, and colorectal cancer equated to half of those deaths.

Large percentages of each of those cancers can be prevented or treated if caught early. “We have designed a therapy that can help recruit immune cells to kill cancer and also help repair bone and tissues damaged by tumors,” said Dr. Figueiredo, who is working with the Purdue Research Foundation Office of Technology Commercialization to patent the innovation. “One of the best features of this technology is that it shows great promise in enabling treatment for many other cancers and diseases that could benefit from halting tumor growth and promoting bone repair.”

The therapy technology is presented in the journal Molecular Therapy: Methods & Clinical Development.  The Purdue team used a protein called interleukin-27, or IL-27, which has shown promise in reducing tumor growth and helping stop cancer from spreading in the body. IL-27 is a cytokine, a kind of protein secreted by cells of the immune system that act as chemical messengers and can help the immune system target cancer and other diseases.

An illustration of protein working to stop tumor growth
Cancer scientists at Purdue aim to use protein power to stop tumor growth and repair damaged bone and tissue.

“Immune cells are naturally attracted to areas of the body with lots of signals that come from proteins such as IL-27,” Dr. Figueiredo said. “So, with our novel approach of targeting the IL-27 to the tumor or bone cells, we can use these proteins to produce signals that bring healthy cells to areas of the body with cancer or other disease and kill the tumors and begin the process of repairing bone and other musculoskeletal tissues.”

Dr. Figueiredo said the new Purdue therapy technology has applications for people and animals with many different types of cancer, including breast and lung, and other diseases where protein targeting could improve the immune system’s response.

The research team and the Purdue Research Foundation Office of Technology Commercialization are looking for partners for this cancer therapy technology. For more information on licensing and other opportunities, contact Joseph Kasper of OTC at jrkasper@prf.org.  Click here to view a complete news release about the research.

Writer(s): Chris Adam, Purdue News Service | pvmnews@purdue.edu

Recent Stories

DVM and Veterinary Technology students gain job opportunity insights at fall PVM Career Fair

Purdue Veterinary Medicine's Fall Career Fair brought veterinary and veterinary technology students together with employers on October 30 at the Purdue Memorial Union. Students explored career opportunities, internships and externships while meeting representatives from veterinary practices and organizations.

In Memory: Dr. Mary Beth Leininger (PU DVM ’67)

Purdue Veterinary Medicine remembers Dr. Mary Beth Leininger (DVM 1967), who died November 6, 2026, at age 83. The first woman elected president of the American Veterinary Medical Association, she spent nearly three decades in private practice and held leadership positions in veterinary medicine, industry and education.

“Paws Up” for Kayla Fuqua – brought to you by the PVM Wellness Committee

Kayla Fuqua, the day-shift Emergency and Critical Care receptionist at our veterinary hospital, is this week's Paws Up honoree. A colleague recognized her for supporting clients, coworkers and veterinary students, answering questions and helping her department during busy shifts.

MMAS Symposium at Purdue provides hands-on learning about Medicine of Mammalian and Avian Species

More than 80 participants joined Purdue Veterinary Medicine's 2026 Medicine of Mammalian and Avian Species Symposium on October 31 and November 1. Organized by the Exotic Animal Club, the two-day event combined presentations on exotic animal medicine with hands-on training in parrot handling, rabbit examinations, avian clinical pathology and other specialized topics.

Costumed characters boost Halloween spirits in Lynn Hall

Halloween brought Minions, the Lorax, Super Mario Bros. characters and plenty of other costumes to Purdue Veterinary Medicine. Students, faculty and staff celebrated with costume contests, trick-or-treating and a Halloween dessert competition in Lynn Hall, the Reed ADDL and the Veterinary Hospital.